-
FSCDR Presents Positive Results from Case Study of Voxelotor (GBT440) in Sickle Cell Disease Patient
Additional Photographs Added as of April 5, 2023. Some text has been updated to reflect present-day. HOLLYWOOD, Fla., — Oct.Read More…
Read More
Additional Photographs Added as of April 5, 2023. Some text has been updated to reflect present-day. HOLLYWOOD, Fla., — Oct.Read More…
Read More